908 Devices (MASS) Deferred Taxes (2023 - 2024)
908 Devices (MASS) posted quarterly Deferred Taxes of -$73000.0 for Q4 2024, down 10.61% year-over-year from -$81661.0 in Q1 2024, and down 1.39% quarter-over-quarter from -$72000.0 in Q3 2024.
908 Devices (MASS) Deferred Taxes (2023 - 2024) Analysis & Trends
908 Devices (MASS) has reported Deferred Taxes for 2 consecutive years, with -$73000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Deferred Taxes fell 10.61% year-over-year to -$73000.0; the TTM figure through Dec 2024 stood at -$283000.0 (up 7.21% YoY), while the FY2024 annual figure was -$283000.0, up 7.21% from the prior year.
- Deferred Taxes declined to -$73000.0 in Q4 2024 per MASS's latest filing, from -$72000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at -$50000.0 in Q1 2023 and bottomed at -$117000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 107.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 17.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | -181.30 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -300,000.00 |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 235.96 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 600,000.00 |
| 10 | 908 Devices | 398.03 Mn | 296.50 Mn | 8.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -73,000.00 |
| Sep 30, 2024 | -72,000.00 |
| Jun 30, 2024 | -68,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Dec 31, 2023 | -66,000.00 |
| Sep 30, 2023 | -117,000.00 |
| Jun 30, 2023 | -72,000.00 |
| Mar 31, 2023 | -50,000.00 |